<DOC>
	<DOCNO>NCT01100853</DOCNO>
	<brief_summary>Until positive result find oral naltrexone , medication effective amphetamine dependence . The primary aim pilot study replicate finding Swedish team show oral Naltrexone prevent relapse amphetamine addiction extend result randomize treatment-seeking amphetamine addict patient 6 month course VIVITROL ( naltrexone extended-release injectable suspension ) VIVITROL placebo . Patients group receive drug counseling . VIVITROL administer monthly may better test efficacy tablet must take daily .</brief_summary>
	<brief_title>Extended Release Naltrexone Treating Amphetamine Dependence Iceland</brief_title>
	<detailed_description />
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Age 18 ; 2 . Diagnosis amphetamine dependence define DSMIVTR 10 day amphetamine use past month , patient clinician identify amphetamine dependence main problem ; 3 . Abstinent substance ( alcohol , amphetamine , cannabinoid , cocaine , hallucinogen , opioids , benzodiazepine [ unless use treat alcohol withdrawal ] least 7 day prior receive study drug placebo ; 4 . Provision telephone numbers/contacts three people likely know locate unable contact directly ; 5 . Successfully complete 710 day assessment study baseline measure Vogur 1 . Any liver test &gt; 5 time top limit normal ; Physiologically dependent opioids substance ( nicotine except ) time admission Vogur ; 2 . Suspected known concomitant use opioid analgesic , positive opioid urine drug test positive naloxone challenge : 3 . Schizophrenia , Bipolar I nonsubstance relate psychotic disorder ; Severely depress , suicidal homicidal : Dementia : Inability understand informed consent ; 4 . Planning move Reykjav√≠k area enter jail within next 12 month ; 5 . Likely receive opioid analgesic next 6 month associate possible schedule surgery procedure ; 6 . Known hypersensitivity naltrexone , polyactidecoglycolide ( PLG ) ; carboxymethylcellulose , component diluent ; 7 . Female subject pregnant lactating , child bear potential use acceptable method birth control ; 8 . A body habitus precludes use customized needle intramuscular injection , base clinical judgment ; 9 . Use investigational agent past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>amphetamine dependence</keyword>
	<keyword>amphetamine injection</keyword>
	<keyword>VIVITROL/VIVITROL placebo</keyword>
	<keyword>amphetamine craving</keyword>
</DOC>